2022
DOI: 10.1002/cpz1.555
|View full text |Cite|
|
Sign up to set email alerts
|

Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells

Abstract: Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide and is caused by the degeneration and loss of dopamine (DA) neurons in the ventral midbrain (VM). The focal and progressive degeneration of DA neurons in the VM makes PD a particularly attractive target for cell‐based therapies. Human pluripotent stem cells (hPSCs) offer unprecedented opportunities to model the development and functional properties of human DA neurons in a dish. The use of human in vitro models based on hPS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 33 publications
1
14
0
Order By: Relevance
“…The correct developmental identity was confirmed by the presence of vMB floorplate progenitor markers LMX1A, FOXA2, and OTX2 (figure 3(c)). Coexpression of these markers at day 16 is in line with previous work on vMB organoids [18,30] and the reference 2D protocol for the generation of vMB dopamine (DA) neurons based on dual-SMAD inhibition and vMB patterning with SHH and GSK3i, followed by vMB progenitor caudalization with FGF8b [34,35]. Correct vMB patterning was further verified by RT-qPCR (figure S1a).…”
Section: Characterization Of Human Vmb Organoid Formationsupporting
confidence: 85%
See 1 more Smart Citation
“…The correct developmental identity was confirmed by the presence of vMB floorplate progenitor markers LMX1A, FOXA2, and OTX2 (figure 3(c)). Coexpression of these markers at day 16 is in line with previous work on vMB organoids [18,30] and the reference 2D protocol for the generation of vMB dopamine (DA) neurons based on dual-SMAD inhibition and vMB patterning with SHH and GSK3i, followed by vMB progenitor caudalization with FGF8b [34,35]. Correct vMB patterning was further verified by RT-qPCR (figure S1a).…”
Section: Characterization Of Human Vmb Organoid Formationsupporting
confidence: 85%
“…Human vMB organoids were generated by following previously published protocol [18,30] in both conventional wells and the 3D printed platform. Single-cell suspension was generated by detaching hPSCs from the culturing dish using 0.5 mM Accutase (Thermo Fisher Scientific).…”
Section: Vmb Organoid Culturementioning
confidence: 99%
“…Previously, human embryonic stem cells were used as a source of pluripotent cells; however, in recent years, they have mostly been replaced by iPSCs [ 140 , 141 , 142 , 143 , 144 ]. As an example, a recent study analyzed single-cell RNA sequencing of the human fetal midbrain at 7.5 weeks of gestation and their subsequent differentiation into hMLOs [ 145 ]; however, the significance of using fetal midbrain remains uncertain.…”
Section: Exploring Transcriptional Modulation Downstream Of Epigeneti...mentioning
confidence: 99%
“…In particular, the diversity of differentiation protocols for human neural organoids poses a unique challenge for organoid quality control that can be met by meta-analytic approaches. Neural organoids can either be undirected 25 (multiple brain region identities) or directed (specific brain region identity) with an increasing number of protocols striving to produce a wider variety of regionspecific organoids 11,[26][27][28][29][30][31][32][33][34][35][36][37] . Meta-analytic primary tissue/organoid comparisons across differentiation protocols stand to derive generalizable quality control metrics applicable to any differentiation protocol, fulfilling a currently unmet need for unified quality control metrics across heterogeneous neural organoids.…”
Section: Introductionmentioning
confidence: 99%